Integra Therapeutics, backed by Columbus and Invivo, to receive up to €10.5 million from European Commission for its FiCAT advanced therapies platform

by Columbus Venture Partners

Integra Therapeutics, a global leader in creating cutting-edge gene writing tools to make advanced therapies safer and more effective, will receive a grant of €2.5 million and equity investment of u...

Read more

Integra Tx secures €4.5-million in funding from Advent France Biotechnology, Invivo Capital and Takeda Ventures

by Invivo Capital

Integra Therapeutics (Integra Tx), a biotechnology company that is creating next-generation gene editing tools to boost the efficiency and safety of advanced therapies, has completed its first round o...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Alantra advises Precinmac on its acquisi...

by Alantra

This transaction reinforces Alantra’s continued momentum in Aerospac...

Photos Stream